70 related articles for article (PubMed ID: 14647880)
1. Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia.
Filip R; Possemiers S; Heyerick A; Pinheiro I; Raszewski G; Davicco MJ; Coxam V
J Nutr Health Aging; 2015 Jan; 19(1):77-86. PubMed ID: 25560820
[TBL] [Abstract][Full Text] [Related]
2. Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial.
Gregori G; Pivodic A; Magnusson P; Johansson L; Hjertonsson U; Brättemark E; Lorentzon M
JAMA Netw Open; 2024 Jun; 7(6):e2415455. PubMed ID: 38865129
[TBL] [Abstract][Full Text] [Related]
3. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Warming L; Ravn P; Christiansen C
Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
Kang JH; Dong Z; Shin SH
J Microbiol Biotechnol; 2023 Dec; 33(12):1552-1562. PubMed ID: 37674385
[TBL] [Abstract][Full Text] [Related]
6. Update on Menopausal Hormone Therapy for Fracture Prevention.
Stepan JJ; Hruskova H; Kverka M
Curr Osteoporos Rep; 2019 Dec; 17(6):465-473. PubMed ID: 31741221
[TBL] [Abstract][Full Text] [Related]
7. Optimization of roasting conditions through antioxidant and anti-inflammatory activities of
Kim AJ
Food Sci Biotechnol; 2016; 25(4):1175-1182. PubMed ID: 30263391
[TBL] [Abstract][Full Text] [Related]
8. Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pAR
Gravina GL; Marampon F; Sanità P; Festuccia C; Forcella C; Scarsella L; Jitariuc A; Vetuschi A; Sferra R; Colapietro A; Carosa E; Dolci S; Lenzi A; Jannini EA
Oncotarget; 2017 Dec; 8(69):113792-113806. PubMed ID: 29371946
[TBL] [Abstract][Full Text] [Related]
9. Long-term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
[TBL] [Abstract][Full Text] [Related]
10. Bioidentical hormones for women with vasomotor symptoms.
Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavone: The multipurpose phytochemical (Review).
Wang Q; Ge X; Tian X; Zhang Y; Zhang J; Zhang P
Biomed Rep; 2013 Sep; 1(5):697-701. PubMed ID: 24649012
[TBL] [Abstract][Full Text] [Related]
12. Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.
Post TM; Cremers SC; Kerbusch T; Danhof M
Clin Pharmacokinet; 2010; 49(2):89-118. PubMed ID: 20067335
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
Byrjalsen I; Leeming DJ; Qvist P; Christiansen C; Karsdal MA
Osteoporos Int; 2008 Mar; 19(3):339-48. PubMed ID: 17846859
[TBL] [Abstract][Full Text] [Related]
14. Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study.
Nielsen TF; Ravn P; Bagger YZ; Warming L; Christiansen C
Osteoporos Int; 2004 Feb; 15(2):168-74. PubMed ID: 14647880
[TBL] [Abstract][Full Text] [Related]
15. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
Delmas PD; Pornel B; Felsenberg D; Garnero P; Hardy P; Pilate C; Dain MP
Bone; 1999 May; 24(5):517-23. PubMed ID: 10321913
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
Arrenbrecht S; Boermans AJ
Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
[TBL] [Abstract][Full Text] [Related]
18. Estrogen therapy for osteoporosis in the modern era.
Levin VA; Jiang X; Kagan R
Osteoporos Int; 2018 May; 29(5):1049-1055. PubMed ID: 29520604
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-intranasal: a review of its use in the management of menopause.
Dooley M; Spencer CM; Ormrod D
Drugs; 2001; 61(15):2243-62. PubMed ID: 11772138
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
